We examine how AI is changing the future of work — and how, in many ways, that future is already here. Every tech company you can think of is jumping on the generative AI bandwagon and touting new ...

pengdows.crud is a SQL-first data access library for .NET 8+. It favors explicit SQL, inspectable command builders, and provider-aware execution over ORM-style query generation. No LINQ. No tracking.

Это простое CRUD-приложение (Create, Read, Update, Delete) для управления книгами, построенное с использованием FastAPI, SQLAlchemy (асинхронный), и базы данных SQLite.

In a stealth move fitting of an announcement it wants to hide, the government has come up with a “do nothing” solution to a desperate military need – a decision that’s as feeble as the equipment ...

Trials of the British Army's Ajax armoured vehicle will be "proceeding cautiously" after they were halted last year, a defence minister has said. A decision was made to stop using the Ajax after ...

General Dynamics said the safety of soldiers 'is, and has always been, our highest priority'. Trials of the Army's troubled Ajax armoured vehicles will resume "cautiously", with the defence minister ...

Trials of the Army's troubled Ajax armoured vehicles will resume "cautiously", with the defence minister acknowledging more work is needed to "rebuild confidence" in the transportation. Testing of the ...

Eli Lilly LLY-0.00%increase; green up pointing triangle continued its recent buying spree, agreeing to pay up to $2.3 billion for Ajax Therapeutics in a deal that bolsters the drugmaker’s blood-cancer ...

Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to expand its oncology pipeline. Lilly has been ...

April 27 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up ‌to $2.3 billion in cash, as the U.S. drugmaker looks to ...

Eli Lilly’s run of near-weekly acquisitions still shows no sign of letting up, with the Big Pharma now buying Ajax Therapeutics for its clinical-stage myelofibrosis therapy. At the center of the deal ...

April 27 (Reuters) - Eli Lilly ⁠said ⁠on Monday it would ⁠buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to ‌expand its oncology ...